Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

American Woodmark Corporation (AMWD) and Goldman Sachs Group Inc. (GS) Register Noteworthy Insider Selling; Insider Buying Observed at Three Other Companies

Page 1 of 3

Numerous studies conclude that corporate insiders earn significant abnormal profits by trading the securities of their own companies. Interestingly enough, insider trading studies also show that even uninformed outsiders can generate abnormal profits by simply imitating insiders. So is it worth tracking insider trading metrics? Of course it’s worth it!

Although some believe corporate insiders trade on privileged information that is not publicly available, a practice viewed as an unfair and illegal advantage, most corporate insiders usually play by the rules imposed by the SEC when buying and selling shares of their own companies. However, stock market participants should keep in mind that there is an insider trading act that is practically impossible to detect: not trading securities because of insider information. For instance, an insider is considering selling 10,000 shares of his own company, but he quickly finds out that the company is about to receive a buyout offer from another company. The SEC and other stock market participants have no knowledge of the insider’s intent, so he can easily hold onto his 10,000 shares until the offer is made public. Hence, if corporate insiders are selling shares at a rapid pace, it might imply that major positive announcements or events are not anticipated in the short-term future. That said, let’s have a look at a set of noteworthy insider transactions reported with the SEC on Tuesday.

Through extensive research that covered the portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).


Board Member at Struggling Operator of Discount Variety Stores Buys Shares After Plunge

One member of Dollar Tree Inc. (NASDAQ:DLTR)’s Board of Directors purchased some shares earlier this week, soon after the nation’s two biggest dollar-store chains released disappointing financial results. Independent Director Conrad M. Hall snapped up 5,000 shares on Monday for $85.60 each, with all these shares being held in a grantor retained annuity trust that currently owns 55,000 shares. Mr. Hall also owns a direct ownership stake of around 20,875 shares.

Dollar Tree Inc. (NASDAQ:DLTR), a leading operator of discount variety stores offering merchandise at the fixed price of $1.00, has seen its market capitalization plunge by 13% in the past month, reflecting disappointing results for its second fiscal quarter that ended July 30. Soon after releasing the earnings report, analysts at MKM Partners slashed their rating on Dollar Tree to ‘Neutral’ from ‘Buy’ and cut their price target on the stock to $80 from $140, arguing that the anticipate “the downshift at Dollar Tree, which could continue, and a more challenging outlook for Family Dollar, to limit valuation on a stock that has enjoyed one of the highest multiples in retail.” Ken Griffin’s Citadel Advisors LLC upped its position in Dollar Tree Inc. (NASDAQ:DLTR) by 52% during the June quarter to 2.42 million shares.

Follow Dollar Tree Inc (NASDAQ:DLTR)
Trade (NASDAQ:DLTR) Now!

The second page of this article will disclose two companies with fresh noteworthy insider buying, whereas the final page of the article will discuss fresh insider selling registered at two other companies.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!